Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Ricerca biotecnologica

Cambridge, Massachusetts 199.479 follower

Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach.

Developing an innovative new class of medicines requires true innovators and passionate dreamers.

Our employees have chosen to do what is hard and are relentless in the pursuit of new treatments for people living with rare diseases.

Alnylam is the Leading RNAi Therapeutics Company

We are the leading RNAi therapeutics company and have pioneered this entirely new class of medicines. Based on Nobel Prize-winning science, RNAi therapeutics are a powerful approach for the treatment of a wide range of diseases. Since our founding, we have been regularly recognized as a leader and innovator, including being a Science Magazine Top Employer (2019-23), Boston Globe Top Place to Work (2015-23), a Fast Company Best Workplace for Innovators (21-23) and a LinkedIn Top Employer 2024.

Learn More about Alynlam Visit the Alnylam Newsroom

At the Forefront of What's Next for Patients, and Perhaps Your Career Also

We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 2,500 employees are building a diverse, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.

Careers See Office Locations

Alnylam's Culture & Values

Our employees come from diverse backgrounds, representing dozens of countries and more than 20 languages. We have strong values that guide who we hire, what we recognize, what we value, and that serve as the foundation of our culture. Our core values are: - Passion for Excellence - Fiercely Innovative - Commitment to People - Open Culture - Purposeful Urgency

Learn about Our Culture Learn about DE&I at Alnylam

Foto azienda

  • Alnylam Pharmaceuticals, foto 1
  • Alnylam Pharmaceuticals, foto 2
  • Alnylam Pharmaceuticals, foto 3
  • Alnylam Pharmaceuticals, foto 4
  • Alnylam Pharmaceuticals, foto 5
  • Alnylam Pharmaceuticals, foto 6
  • Alnylam Pharmaceuticals, foto 7
  • Alnylam Pharmaceuticals, foto 8
  • Alnylam Pharmaceuticals, foto 9
  • Alnylam Pharmaceuticals, foto 10
  • Alnylam Pharmaceuticals, foto 11
  • Alnylam Pharmaceuticals, foto 12
  • Alnylam Pharmaceuticals, foto 13
  • Alnylam Pharmaceuticals, foto 14
  • Alnylam Pharmaceuticals, foto 15
  • Alnylam Pharmaceuticals, foto 16
  • Alnylam Pharmaceuticals, foto 17
  • Alnylam Pharmaceuticals, foto 18
  • Alnylam Pharmaceuticals, foto 19
  • Alnylam Pharmaceuticals, foto 20

Pagine simili

Sfoglia le offerte di lavoro

Azioni

ALNY

NASDAQ

Ritardo di 20 minuti

236,28 USD

1,44 (0,613%)

Apertura
235,33
Minimo
233,72
Massimo
237,02

Dati da Refinitiv

Vedi altre informazioni su Bing